We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+45.29%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$483M
AUM Growth
+$23M
(+5%)
Cap. Flow
-$62.1M
Cap. Flow
% of AUM
-12.86%
Top 10 Holdings %
Top 10 Hldgs %
9.87%
Holding
378
New
132
Increased
14
Reduced
97
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLX Energy Services
KLXE
|
+$3.31M |
| 2 |
Par Pacific Holdings
PARR
|
+$3.1M |
| 3 |
A10 Networks
ATEN
|
+$3.05M |
| 4 |
Federal Signal
FSS
|
+$2.71M |
| 5 |
Tidewater
TDW
|
+$2.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
+$5.93M |
| 2 |
Cogent Biosciences
COGT
|
+$5.04M |
| 3 |
Lantheus
LNTH
|
+$4.84M |
| 4 |
Sensus Healthcare
SRTS
|
+$4.1M |
| 5 |
Cytokinetics
CYTK
|
+$3.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.56% |
| 2 | Industrials | 17.86% |
| 3 | Technology | 16.26% |
| 4 | Energy | 11.48% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
ADMA Biologics
ADMA
$1.92B
| $6.79M | 1.41% |
1,749,598
+322,438
| +23% | +$995K |
|
2
UFP Technologies
UFPT
$1.84B
| $5.86M | 1.21% |
49,672
+7,260
| +17% | +$774K |
|
3
Rhythm Pharmaceuticals
RYTM
$7B
| $4.8M | 0.99% |
164,695
-34,004
| -17% | -$874K |
|
4
Viking Therapeutics
VKTX
$4.04B
| $4.65M | 0.96% |
+494,940
| New | +$2.21M |
|
5
Target Hospitality
TH
$1.61B
| $4.6M | 0.95% |
304,011
-106,103
| -26% | -$1.43M |
|
6
PDS Biotechnology
PDSB
$38.1M
| $4.36M | 0.9% |
+330,426
| New | +$2.33M |
|
7
Digi International
DGII
$2.52B
| $4.3M | 0.89% |
117,746
-641
| -0.5% | -$24.7K |
|
8
Ceco Environmental
CECO
$4.42B
| $4.25M | 0.88% |
363,995
-524
| -0.1% | -$5.93K |
|
|
9
KLX Energy Services
KLXE
$44.8M
| $4.07M | 0.84% |
+234,913
| New | +$3.31M |
|
|
ACLX
10
DELISTED
Arcellx
ACLX
| $3.98M | 0.82% |
128,525
-761
| -0.6% | -$17.5K |
|
11
Agilysys
AGYS
$2.78B
| $3.96M | 0.82% |
50,028
-197
| -0.4% | -$12.6K |
|
12
MGP Ingredients
MGPI
$378M
| $3.94M | 0.81% |
36,995
-6,163
| -14% | -$689K |
|
13
Impinj
PI
$3.89B
| $3.89M | 0.81% |
35,661
-6,446
| -15% | -$679K |
|
14
Destination XL Group
DXLG
$34.7M
| $3.66M | 0.76% |
542,285
-629
| -0.1% | -$4.03K |
|
15
Transmedics
TMDX
$2.5B
| $3.58M | 0.74% |
57,944
-19,367
| -25% | -$1.03M |
|
|
ETNB
16
DELISTED
89bio
ETNB
| $3.51M | 0.73% |
275,943
+85,225
| +45% | +$767K |
|
|
HDSN
17
Hudson Technologies
HDSN
$267M
| $3.51M | 0.73% |
346,347
-18,990
| -5% | -$186K |
|
|
CBAY
18
DELISTED
Cymabay Therapeutics
CBAY
| $3.45M | 0.71% |
550,470
+210,692
| +62% | +$801K |
|
19
Harrow
HROW
$1.43B
| $3.44M | 0.71% |
232,908
+8,862
| +4% | +$106K |
|
|
BELFB
20
Bel Fuse Inc Class B
BELFB
$3.88B
| $3.43M | 0.71% |
104,333
-40,648
| -28% | -$1.33M |
|
21
Richardson Electronics
RELL
$261M
| $3.41M | 0.71% |
159,655
-7,946
| -5% | -$180K |
|
22
e.l.f. Beauty
ELF
$4.56B
| $3.37M | 0.7% |
60,937
-21,851
| -26% | -$1.07M |
|
23
Huron Consulting
HURN
$1.82B
| $3.36M | 0.7% |
46,324
-254
| -0.5% | -$18.7K |
|
|
RXDX
24
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $3.36M | 0.69% |
30,504
-19,550
| -39% | -$1.27M |
|
25
Aehr Test Systems
AEHR
$2.48B
| $3.32M | 0.69% |
165,102
-144,538
| -47% | -$3.09M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q4 2022 Portfolio in Review
As of Q4 2022, EAM Investors held 378 positions worth $483M, up 5% from $460M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
EAM Investors withdrew a net $62.1M in Q4 2022, closing 129 positions and reducing 97 holdings. Its most notable exit was Concert Pharmaceuticals, Inc., an estimated $5.93M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Technology.
Against the trend, EAM Investors opened a new position in KLX Energy Services worth $4.07M.
- EAM Investors's largest Q4 2022 buy was KLX Energy Services: 234,913 shares worth $4.07M.
- EAM Investors added most to Modine Manufacturing in Q4 2022, an estimated $1.28M increase.
- EAM Investors's biggest Q4 2022 reduction was Aehr Test Systems, cutting an estimated $3.09M.
- EAM Investors fully exited Concert Pharmaceuticals, Inc. in Q4 2022, selling an estimated $5.93M.
- EAM Investors's ten largest holdings make up 9.9% of its $483M portfolio in Q4 2022.
- EAM Investors opened 132 new positions and closed 129 in Q4 2022.
- EAM Investors's portfolio value rose 5% quarter-over-quarter to $483M.
Based on EAM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.